TAC-002

N/A

Report date: 2023/01/31 18:33:20

Base Information

Drug NameTAC-002

Drug Alias NameTAC-002

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionImmunomodulatorsToll like receptor 9 agonists

TargetsToll like receptor 9

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAlx Oncology Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A